[Skip to Navigation]
Views 12,082
Citations 0
Viewpoint
April 9, 2021

Meeting the Challenge of Caring for Persons Living With Dementia and Their Care Partners and Caregivers: A Report From the National Academies of Sciences, Engineering, and Medicine

Author Affiliations
  • 1Kaiser Permanente Washington Health Research Institute, Seattle
  • 2The National Academies of Sciences, Engineering, and Medicine, Washington, DC
JAMA. 2021;325(18):1831-1832. doi:10.1001/jama.2021.4928

Millions of people are living with dementia throughout the US and around the world. Dementia care has improved since the 1970s, with significant declines in previously common, yet harmful, practices such as mechanical restraining devices, forced feeding techniques, and overuse of antipsychotic medications. These harm-reducing advances are not sufficient, however. Many people still lack access to high-quality care and are not living as well as they might. Racial and ethnic minorities and other disadvantaged groups continue to experience deep and persistent inequities, such as lower-quality care in nursing homes and greater use of feeding tubes.1,2 The COVID-19 pandemic has further exacerbated the social isolation, risk of abuse of older persons, and other challenges encountered by many persons living with dementia and their care partners and caregivers.3 To move forward, dementia care needs to build on previous advances in harm reduction by also incorporating more focus on promoting well-being, respecting personhood, and supporting people’s preferences, strengths, and abilities. Such an approach reframes aging to late life as a reward rather than something to dread.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×